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Brain-tethered T cells
 
On page 1805, Kawakami et al. show that 
antigen-specific CD4
 
 
 
 T cells that attack the 
brain become stationary within brain tissue, 
whereas nonspecific T cells cruise through 
without stopping. These intravital images—the 
first to capture T cells launching an autoimmune 
attack on the brain—suggest that antigen-
specific T cells behave similarly in dense brain 
tissue as they do in lymph nodes.
Activated CD4
 
 
 
 T cells specific for the 
endogenous brain protein myelin basic protein 
(MBP) trigger fatal encephalomyelitis in a rat 
model of multiple sclerosis. These cells migrate 
into the central nervous system (CNS) where 
they become reactivated.
Previous studies by this group showed that both antigen-specific and 
nonspecific T cells gain access to the CNS, but only specific cells become 
reactivated once there. Kawakami et al. now show that a subset of MBP-specific 
T cells—likely those that have encountered antigen—stopped moving inside 
the brain, appearing tethered to a fixed point. T cells specific for a control 
antigen kept moving, suggesting that the presence of antigen was required 
for T cells to stop moving and to trigger disease.
The authors were surprised to find that T cells move as rapidly through the 
dense brain tissue as in the more aqueous environment of the lymph nodes. How 
they do this is not known but the authors suggest that the T cells may produce 
proteases that help clear a path through the compact tissue.
A subset of MBP-specific 
T cells (green) become 
stationary in the brain 
during EAE, presumably 
after engaging their antigen 
on antigen-presenting cells 
(red).
 
Signaling commitment
 
A histone modification thought by many to be a crude bulldozer can
contribute to the fine molding of cell behavior, according to a study
on page 1825. Rossig et al. show that histone deacetylase (HDAC)
activity is required for adult progenitor cells to commit to the endothelial
cell lineage. In these cells, HDAC activity was specifically required for the
induction of the transcription factor HoxA9, which may be a master
regulator of endothelial cell commitment.
HoxA9 was able to drive cell differentiation due to its ability to
activate the expression of endothelial cell–specific genes, including
endothelial cell nitric oxide synthase (eNOS). In addition, HoxA9-
deficient mice were unable to recover from ischemic injury, a pro-
cess that requires formation of new endothelial cells from circulating
progenitors.
But the involvement of HDACs in this process may seem counter-
intuitive, as histone deacetylation of gene promoter elements is normally
associated with transcriptional silencing. Indeed, recent reports showed
that eNOS expression itself is suppressed by HDAC activity in nonen-
dothelial cells.
The protein complex responsible for activating HoxA9 expression
was, however, recently shown to contain HDAC proteins. HDACs can
modify nonhistone proteins, including transcription factors, and the
acetylation or deacetylation state of these factors can influence target gene
activation. The authors suspect that modification of nonhistone proteins
may govern the induction of HoxA9.
 
The mark of T reg cells
 
Regulatory T (T reg) cells found in the synovial
fluid of inflamed joints can be identified by
the coexpression of CD4, CD25, and CD27,
according to Ruprecht and colleagues on
page 1793.
Suppression of damaging T cell responses by
CD4
 
 
 
 T reg cells is critical for the prevention of
autoimmune disease. But studying these cells
in the context of disease has been problematic,
largely because CD4
 
 
 
 T reg cells and activated
CD4
 
 
 
 T cells express many of the same surface
molecules and are thus difficult to distinguish.
Although coexpression of CD4 and the high
affinity interleukin (IL)-2 receptor (CD25)
identifies T reg cells in the circulation,
CD25 cannot distinguish between T reg cells
and local effector T cells, which up-regulate
this molecule upon activation.
Ruprecht et al. now show that CD4
 
 
 
CD25
 
 
 
 T reg cells found in the inflamed joints
of children with autoimmune arthritis can be
distinguished from their CD4
 
 
 
CD25
 
 
 
 effector
T cell counterparts by the expression of the
TNF receptor family member CD27—a mole-
cule that is down-regulated on activated T
cells. CD27 expression identified T reg cells in
these patients, as the ability to suppress T cell
proliferation in vitro resided solely in the
CD4
 
 
 
CD25
 
 
 
CD27
 
 
 
 T cell subset.
But why does an autoimmune response
develop in these patients despite an abun-
dance of T reg cells at the site of disease? The
authors suggest that the cytokines IL-7 and
IL-15, which were detected in the patients’
synovial fluid, might be to blame, as the
combination of these cytokines reversed the
in vitro ability of the T reg cells to inhibit T
cell proliferation.
CD4  regulatory T cells in the synovial tissues of a 
juvenile arthritis patient coexpress CD25 (red) 
and CD27 (green). 
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